B Group, Inc.: 13F holdings
CIK 20434762026Q2
| Positions | 19 |
|---|
| Reported value | $213.0m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 19 (-1 vs prior quarter) |
|---|
| Reported value | $213.0m (+57.9%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| ADMA ADMA BIOLOGICS INC | 3,262,542 | $27.3m | 12.8% |
| PALISADE BIO INC | 11,414,285 | $23.9m | 11.2% |
| NRX PHARMACEUTICALS INC | 4,091,767 | $16.7m | 7.9% |
| FAETH THERAPEUTICS INC | 610,169 | $15.3m | 7.2% |
| TSHA TAYSHA GENE THERAPIES INC | 1,800,556 | $12.3m | 5.8% |
| PRAX PRAXIS PRECISION MEDICINES I | 33,237 | $11.1m | 5.2% |
| CLLS CELLECTIS S A | 3,281,501 | $9.8m | 4.6% |
| ZLAB ZAI LAB LTD | 450,646 | $8.6m | 4.0% |
| GPCR STRUCTURE THERAPEUTICS INC | 140,000 | $7.5m | 3.5% |
| ORKA ORUKA THERAPEUTICS INC | 75,000 | $7.1m | 3.4% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2043476")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples